NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,812.80+₹51.80 (+2.94%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
Loading market information…
NSE · KREBSBIO.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:39 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Krebs Biochemicals & Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 25.18% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Krebs Biochemicals & Industries Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1991 and headquartered in Hyderabad, India, Krebs Biochemicals & Industries Limited primarily focuses on the production and distribution of active pharmaceutical ingredients (APIs) across India. The company also innovates by developing biotechnological processes applicable to the medical, agricultural, and industrial sectors. Its current portfolio includes compounds like androstenedione, lovastatin, and simvastatin, which serve as steroid intermediates and anti-cholesterol agents. Furthermore, Krebs Biochemicals is actively developing new products such as amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine, targeting diverse therapeutic applications including anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough relief. The firm also extends its expertise by offering contract manufacturing services to large pharmaceutical and multinational corporations.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,812.80+₹51.80 (+2.94%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
₹8.28+₹0.11 (+1.35%)
Achyut Healthcare Ltd.’s quoted price sits in the upper half of its reported 52-week range, 17.43% below the high.
₹139.95-₹2.60 (-1.82%)
Smruthi Organics Limited’s quoted price sits in the upper half of its reported 52-week range, 20.17% below the high.
₹114.67-₹6.03 (-5.0%)
Par Drugs and Chemicals Limited’s quoted price sits in the lower half of its reported 52-week range, 36.29% below the high.
₹111.85-₹0.80 (-0.71%)
Lactose (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 18.03% below the high.
₹81.25-₹3.36 (-3.97%)
Bal Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 34.79% below the high.
₹50.75-₹1.87 (-3.55%)
Alpa Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 45.92% below the high.
₹29.18-₹0.04 (-0.14%)
Mangalam Drugs & Organics Limited’s quoted price sits in the lower half of its reported 52-week range, 57.34% below the high.
